Drug stocks slip; Sepracor falls on CFO change

BOSTON (MarketWatch) — Drug stocks slipped in early action Thursday as shares of Sepracor Inc. lost ground on news that its chief financial officer was leaving the company. The Amex Pharmaceutical Index eased 0.2% to 299.8 and the Amex Biotechnology Index fell 0.4% to 745.7. Sepracor shares were off 2% at $19.58.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Original post by Forextvblog

Leave a Reply